TÜBINGEN, Germany / BOSTON, USA – May 19, 2017

CureVac AG, the most clinically advanced mRNA company, today announced that the company will present at two upcoming international investor conferences: UBS 2017 Global Healthcare Conference in New York, NY; and Bio€quity Europe in Paris, France.

Executives from CureVac will provide an overview of the company’s business, industry-leading mRNA technology platform, and clinical-stage product pipeline during each presentation and will be available to participate in one-on-one meetings with investors who are registered to attend each conference.

UBS 2017 Global Healthcare Conference
Pierre Kemula, Chief Financial Officer
Monday, May 22, 2017
2:30 – 3:00 pm, ET
Grand Hyatt, New York, NY – Ballroom IV

Bio€quity Europe
Dr. Franz-Werner Haas, Chief Corporate Officer
Monday, May 22, 2017
3:40 – 4:00 pm, CET
Marriott Rive Gauche, Paris, France – Forum EF, Level -1